Battling depression with hallucinogenic fungi

The Walrus quoted Mark Haden, a professor at UBC’s School of Population and Public Health, for a story on how a compound in magic mushrooms was shown to reduce symptoms of treatment-resistant depression.

Haden said there’s no financial incentive for a large pharmaceutical company to sponsor the necessary research so that the drug could become legal.

“Pharmaceutical companies do well when they are providing drugs that are used for daily maintenance,” he said. “There is no business model to support the use of psychedelics, because they are used so incredibly infrequently.”